EUVIMEDEUVIMED entdecken
Open Access

Transplant mice with acute viral infection develop functionally distinct antigen-specific PD-1− and PD-1+ CXCR5+CD8+ T-cell effectors

Jason M Zimmerer iD, Sydney Castellanos, Hatem Aldhahi, Mahmoud Abdel-Rasoul iD, Ravi Dhital iD, Masako Shimamura iD, Ginny L Bumgardner iD

The Journal of Immunology · 01.10.2026 · 215 (10)

DOI: 10.1093/jimmun/vkag286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 24.10.2026. Verfasst von Jason M Zimmerer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Comprehensive Transplant Center, and College of Medicine, The Ohio State University, Columbus, OH, United States. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes, Muromegalovirus, Herpesviridae Infections. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: OSU College of Medicine, OSU Division of Transplant Surgery, American Society of Transplant Surgeons Presidential Student Mentor.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the development, antigen specificity, and effector functions of PD-1− and PD-1+ CXCR5+CD8+ T-cell subsets in transplant mice with acute murine cytomegalovirus (MCMV) infection. MCMV-primed (MCMV-Tet+) or alloprimed (MCMV-Tet−) CD8+ T cells from C57BL/6 mice were flow-sorted and adoptively transferred into MCMV-infected CD8 knockout transplant recipients. Alloantibody titer, quantities of primed germinal center (GC) B cells, anti-MCMV antibody titer, and MCMV viral titer were assessed on day 14 posttransplant. Following adoptive transfer (AT), alloprimed PD-1− (but not PD-1+) CXCR5+CD8+ T cells mediated suppression of alloantibody (1.8-fold) and reduced the quantity of alloprimed (alloTet+) GC B cells (2.4-fold) and CD4+ TFH cells (2.8-fold) but did not impact anti-MCMV antibody levels, the quantity of MCMV-primed GC B cells or CD4+ TFH cells, or MCMV viral titer. Conversely, AT of MCMV-primed (MCMV-Tet+) CXCR5+PD-1−CD8+ T cells into MCMV-infected transplant mice suppressed anti-MCMV antibody (1.7-fold) and reduced the quantity of MCMV-primed GC B cells (3.3-fold) and MCMV-Tet+ CD4+ TFH cells (2.5-fold) but did not impact alloantibody levels, the quantity of alloprimed GC B cells or CD4+ TFH cells, nor MCMV viral titer. Antibody suppression by antigen-specific CXCR5+PD-1−CD8+ T cells is associated with cytotoxic killing of antigen-primed GC B cells in vitro and reduction of antigen-primed GC B-cell quantity in vivo. In contrast, AT of MCMV-primed CXCR5+PD-1+CD8+ T cells reduced MCMV viral titer without influencing anti-MCMV antibody or alloantibody levels. These data indicate that PD-1− and PD-1+ subsets of CXCR5+CD8+ T cells, which emerge acutely after viral infection or transplant, mediate distinct antigen-specific effector functions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorCD8-Positive T-LymphocytesMuromegalovirusHerpesviridae InfectionsCytomegalovirus InfectionsAnimalsReceptors, CXCR5MiceMice, Inbred C57BLMice, KnockoutAdoptive TransferB-LymphocytesGerminal CenterAcute Disease

Stichwörter der Autor:innen

CXCR5hepatocyte transplanthumoral immunitymurine cytomegalovirus

Substanzen

Programmed Cell Death 1 ReceptorReceptors, CXCR5Pdcd1 protein, mouseCXCR5 protein, mouse

Autor:innen und Institutionen

  • Department of Surgery, Comprehensive Transplant Center, and College of Medicine, The Ohio State University, Columbus, OH, United States.
  • Medical Student Research Program, The Ohio State University College of Medicine, Columbus, OH, United States.
  • Center for Biostatistics, The Ohio State University, Columbus, OH, United States.
  • Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.
  • Division of Pediatric Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, United States.

ORCID-Profile: Jason M Zimmerer, Mahmoud Abdel-Rasoul, Ravi Dhital, Masako Shimamura, Ginny L Bumgardner

Förderung

  • OSU College of Medicine
  • OSU Division of Transplant Surgery
  • American Society of Transplant Surgeons Presidential Student Mentor
  • Flow Cytometry Core
  • NCATS NIH HHS
  • NIAID NIH HHS
  • Genomics Core
  • NIH HHS

Zitieren

APA

Zimmerer, J. M., Castellanos, S., Aldhahi, H., Abdel-Rasoul, M., Dhital, R., Shimamura, M., & Bumgardner, G. L. (2026). Transplant mice with acute viral infection develop functionally distinct antigen-specific PD-1− and PD-1+ CXCR5+CD8+ T-cell effectors. The Journal of Immunology, 215(10). https://doi.org/10.1093/jimmun/vkag286

Vancouver

Zimmerer JM, Castellanos S, Aldhahi H, Abdel-Rasoul M, Dhital R, Shimamura M, et al. Transplant mice with acute viral infection develop functionally distinct antigen-specific PD-1− and PD-1+ CXCR5+CD8+ T-cell effectors. The Journal of Immunology. 2026;215(10). doi:10.1093/jimmun/vkag286

BibTeX
@article{Zimmerer2026,
  author = {Zimmerer, Jason M and Castellanos, Sydney and Aldhahi, Hatem and Abdel-Rasoul, Mahmoud and Dhital, Ravi and Shimamura, Masako and Bumgardner, Ginny L},
  title = {Transplant mice with acute viral infection develop functionally distinct antigen-specific PD-1− and PD-1+ CXCR5+CD8+ T-cell effectors},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {10},
  doi = {10.1093/jimmun/vkag286}
}
Kostenlos starten →